medigraphic.com
SPANISH

Revista Médica del Instituto Mexicano del Seguro Social

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2016; 54 (1)

Diagnostic strategies in the Clínica de Tuberculosis of the Hospital General of the Centro Médico Nacional La Raza

Flores-Ibarra AA, Ochoa-Vázquez MD, Sánchez TGA
Full text How to cite this article

Language: Spanish
References: 10
Page: 122-127
PDF size: 620.10 Kb.


Key words:

Mycobacterium tuberculosis, Diagnosis, Tuberculosis.

ABSTRACT

In order to diagnose TB infection, tuberculin skin test and interferon gamma release assay are available. The tuberculin test has a sensitivity of 99 % and a specificity of 95 %. For the detection of interferon gamma in blood there are currently two tests available: TBGold QuantiFERONIn- Tube (with a sensitivity of 0.70 and a specificity of 0.90), and T-SPOTTB (sensitivity 0.90 and specificity 0.93). To diagnose the disease, a microscopy of direct smears for acid-fast bacilli is used if the physician is facing an extensive cavitary lung disease due to M. tuberculosis (this test has a high sensitivity: 80-90 %). The most common staining techniques used are Ziehl-Neelsen and Kinyoun, and the fluorescent technique, auramine-rhodamine. The culture is the gold standard and it has a sensitivity of 80 % and a specificity over 90 %, but the results take weeks. The nucleic acid amplification test has an overall sensitivity and specificity of 0.85 and 0.97, respectively. In the presence of a pleural effusion is necessary to perform a pleural biopsy for culture with a sensitivity of 85 % if it is percutaneous and 98 % if it was taken by thoracoscopy. The adenosine deaminase can be determined in pleural fluid with a sensitivity and specificity of 95 %.


REFERENCES

  1. González J, García J, Anibarro L, Vidal R, Esteban J, Blanquer R et al. Documento de consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis. Arch Bronconeumol. 2010;46(5):255-74.

  2. ACCP Pulmonary Medicine Board Review: 26th Edition; 2012. DOI: 10.1378/pulm.26.0

  3. Grupo de trabajo de la Guía de Práctica Clínica sobre el Diagnóstico, el Tratamiento y la Prevención de la Tuberculosis. Centro Cochrane Iberoamericano. Guía de Práctica Clínica sobre el Diagnóstico, el Tratamiento y la Prevención de la Tuberculosis. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad de Cataluña; 2009.

  4. Caminero-Luna J. Guía de la Tuberculosis para Médicos Especialistas. París: Unión Internacional Contra la Tuberculosis y Enfermedades Respiratorias; 2003.

  5. NICE clinical guideline 117. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control; 2011.

  6. Secretaría de Salud. Norma Oficial Mexicana NOM- 006-SSA2-1993, Para la prevención y control de la tuberculosis en la atención primaria a la salud. México: SSA; 1993.

  7. World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. WHO library cataloguing Publication Data; 2011.

  8. Peña J, Ferraro M, Hoffman C, Branda J. Growth Detection Failures by the Nonradiometric Bactec MGIT 960 Mycobacterial Culture System. Journal of Clinical Microbiology. 2012(6):2092-5.

  9. Ling DI, Flores LL, Riley WL, Pai NN, Commercial Nucleic-Acid Amplification Tests for Diagnosis of Pulmonary Tuberculosis in Respiratory Specimens: Meta-Analysis and Meta-Regression. PLoS ONE. 2008;3(2):e1536.

  10. Garrido V, Ferrer J, Hernández L, de Pablo A, Peréz E, Rodríguez F. Diagnóstico y tratamiento del derrame pleural. Arch Bronconeumol. 2006;42(7)349-72.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Inst Mex Seguro Soc. 2016;54